BCL2 and breast carcinoma: Collectively, our data demonstrate that both (1) and (2) increase membrane permeability, decrease MMP and activate caspases involved in the intrinsic apoptosis pathway in breast cancer cells by modulating BCL2 and p38 MAPK signaling molecules.